Sitemap

Home

The Group's

Business model and strategy

Business model and strategy

Our values

Our values

Key figures

Key figures

Corporate governance

Board of Directors

Executive team

By-laws and Internal regulations of the Board of Directors

Corporate governance

Human resources

Human resources

Useful Information

Useful Information

.

Business model and strategy

Products

R&D

Principles

Research & Development

Projects

Development product portfolio

Investors

The BioAlliance share

Financial analysts

Shareholding structure and capital as of December 31, 2011

Stock price

Financial calendar

Financial calendar

Press releases

Press releases

Key figures

Key figures

Publications

Annual reports / Registration Documents

Half-year financial report

Quarterly financial information

Financial presentations

Financial transactions

Shareholders' Meetings

Shareholders' Meetings

AMF regulated information

AMF regulated information

Total number of voting rights and shares

Annual financial reports

Half-year financial reports

Quaterly financial information

Report on corporate governance and internal controls

Statutory auditors' fees

Share repurchase programs

Prospectuses related to public offerings

Press releases

Shareholders' meeting - preparatory documents

Liquidity contract statements

Media

Press releases

Press releases

Press kits

Focus on Taste and Cancer

Vidéos

Vidéos

Business Development

Sitavig, an approved drug in the US

Sitavig, an approved drug in the US

Business Development

Business Development